MARK ZOBECK to Multidrug Resistance-Associated Proteins
This is a "connection" page, showing publications MARK ZOBECK has written about Multidrug Resistance-Associated Proteins.
Connection Strength
0.805
-
Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene. Pediatr Blood Cancer. 2021 08; 68(8):e29036.
Score: 0.744
-
Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia. Pharmacotherapy. 2025 Jan; 45(1):4-11.
Score: 0.060